What is the primary purpose of prophylactic anticoagulation in high-risk patients?

What is the primary purpose of prophylactic anticoagulation in high-risk patients?

• A. To prevent genetic disorders
• B. To reduce comorbidities
• C. To facilitate familial genetic counseling
• D. To cure existing health problems

Answer: (B)

The primary purpose of prophylactic anticoagulation in high-risk patients is to reduce the risk of thromboembolic events, such as deep vein thrombosis (DVT) and pulmonary embolism (PE), particularly in individuals who may have risk factors like recent surgery, immobility, cancer, or certain medical conditions. By administering anticoagulants preventively, healthcare providers aim to mitigate the likelihood of these potential complications, which can be life-threatening and lead to increased morbidity.

While reducing comorbidities can be a secondary benefit of effective anticoagulation (as preventing thromboembolic events may help keep patients healthier overall), the main focus remains on the prevention of specific cardiovascular events related to clot formation. Other options like preventing genetic disorders, facilitating familial genetic counseling, or curing existing health problems do not directly align with the goals of prophylactic anticoagulation strategies, which are specifically aimed at preventing life-threatening clots in vulnerable patients.